Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F6A71
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,726
Award facts
- Contract value 100% obligated
- $24,726.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,726.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg auto-injector pens on January 29, 2026, with completion scheduled for January 30, 2026. This competitively awarded, non-set-aside contract is performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills such delivery orders for specialty medications across multiple therapeutic domains. Cosentyx is a biologic immunosuppressant used primarily for autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. This order represents routine pharmaceutical supply chain support to Defense Health Agency and other federal military treatment facilities, demonstrating the contractor's ongoing role in maintaining essential medication inventory for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F6A71?
SPE2DR26F6A71 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F6A71 worth?
The government has obligated $24,726 on SPE2DR26F6A71.
Is contract SPE2DR26F6A71 an order under another contract?
Yes. SPE2DR26F6A71 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F6A71 competed?
The extent of competition for SPE2DR26F6A71 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award